Bone marrow transplantation for aplastic anaemia (author's transl)

Klinische Wochenschrift
H J KolbD Schendel

Abstract

From March 1975 until May 1980 twelve patients with severe aplastic anemia were grafted with bone marrow from HLA-identical siblings by the Munich Cooperative Group for Bone Marrow Transplantation. Six patients are alive between 10 months and more than 5 years after grafting with normal blood values and marrow. One patient is treated as an out patient for chronic localized graft-versus-host disease (GvHD), five patients are well and without treatment. Six patients have died, one patient with a cerebral hemorrhage the day before transplantation, three patients following rejection of grafts 32, 40 and 55 days after grafting, one patient with severe GvHD 85 days after grafting and one patient, probably with interstitial pneumonia, following cerebral hemorrhage. Three of 6 patients who were conditioned with Cyclophosphamide (CY) only died following rejection of the graft. Two adults who were conditioned with CY and "total lymphoid irradiation" and three children, who wer given unirradiated leukocyte concentrates from the marrow donor after grafting, did not reject their grafts. The results of the Munich-Cooperative Group for Bone Marrow Transplantation are comparable to those of large, specialized centers for bone marrow transplant...Continue Reading

References

Oct 30, 1976·Lancet·UNKNOWN UCLA Bone Marrow Transplant Team
Feb 1, 1978·The Journal of Experimental Medicine·D G NathanD E Housman
Jan 6, 1977·The New England Journal of Medicine·R HoffmanL R Wasserman
Dec 30, 1976·The New England Journal of Medicine·D T BaranM R Klemperer
Aug 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·W A KaganR A Good
Feb 5, 1972·Lancet·E D ThomasK E Lerner
Apr 22, 1972·Lancet·S Davis, A D Rubin
Jul 12, 1973·The New England Journal of Medicine·N T Shahidi
Jun 1, 1974·British Journal of Haematology·K Ajlouni, T D Doeblin
Jul 14, 1966·The New England Journal of Medicine·R P PillowE D Thomas
Jun 1, 1970·Experimental Cell Research·T CasperssonC Johansson
Jan 1, 1980·Annals of Internal Medicine·R StorbP L Weiden
Jan 1, 1980·Haematology and Blood Transfusion·B NetzelS Thierfelder
Jun 12, 1980·The New England Journal of Medicine·W B ErshlerN T Shahidi
Dec 5, 1964·Nature·P I TERASAKI, J D MCCLELLAND
Apr 17, 1965·British Medical Journal·S M LEWIS

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.